Abstract

PreScription: Two Lessons in 17-Hydroxyprogesterone

Author(s): Menighan Thomas E

Issue: Jul/Aug 2011 - Volume 15, Number 4

View All Articles in Issue

Page(s): 268

Download in electronic PDF format for $75

Abstract

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2011 Pg. 268	PreScription: Two Lessons in 17-Hydroxyprogesterone Author(s): Menighan Thomas E
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 95-102	U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Author(s): Yoch Doug
Sep/Oct 2007 Pg. 397-398	Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 2: Developing Essential Standard Operating Procedures Author(s): Cabaleiro Joe
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
Jan/Feb 2018 Pg. 7-16	Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Author(s): Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Nov/Dec 2016 Pg. 469-474	Why Become Pharmacy Compounding Accreditation Board Accredited? Author(s): Dillon L Rad
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 208	The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Author(s): Miller David G
Jan/Feb 2012 Pg. 86-87	PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone Author(s): Cabaleiro Joe
Sep/Oct 2008 Pg. 432-433	Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 4L Tips for "Last Minute" Preparations Author(s): Cabaleiro Joe
Nov/Dec 2014 Pg. 526-527	PostScription: Pharmacy Compounding Accreditation Board: Past, Present, and Future Author(s): Cabaleiro Joe
Jul/Aug 2020 Pg. 296-297	Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Author(s): Brunner Scott
Jan/Feb 2019 Pg. 32-33	U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line Author(s): Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A
Mar/Apr 2008 Pg. 174-175	PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care Author(s): Murry Tom
Jul/Aug 2007 Pg. 326-327	Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration Author(s): Kupiec Tom, Kemp Jesse
Jul/Aug 2007 Pg. 297-298	Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 1: An Overview Author(s): Cabaleiro Joe
Sep/Oct 2020 Pg. 371-379	Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Mar/Apr 2011 Pg. 92	PreScription: Cabaleiro Brings Solid Record to the Pharmacy Compounding Accreditation Board Author(s): Menighan Thomas E